Tag: GLP-1 drugs
Trump’s GLP-1 Drug Deal with Eli Lilly and Novo Nordisk Falls Short of Cost Control Goals
The Trump administration's voluntary pricing agreement with Eli Lilly and Novo Nordisk to control GLP-1 drug costs contains structural loopholes…
U.S. Healthcare Spending Surged 7.3% in 2025, Driven by GLP-1 Adoption and Increased Care Utilization
U.S. healthcare spending surged 7.3% to approximately $6 trillion in 2025, driven by widespread adoption of expensive GLP-1 weight-loss and…
Submit Your Paper to GMJ
No APC until January 2027.